Study Shows Protein Inhibitor as Potential Treatment Approach for Common Mutations Found in Non-Hodgkin Lymphomas: University of Texas
January 08, 2020
January 08, 2020
HOUSTON, Texas, Jan. 8 [TNSmedicalresearch-Cancer Discovery journal] -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
- Findings may create immunotherapy options for lymphomas caused by CREBBP mutations
* * *
A study at The University of Texas MD Anderson Cancer Center demonstrated a potential new approach to treating two of the most common subtypes of lymphoma through manipulation of molecular pro . . .
* * *
- Findings may create immunotherapy options for lymphomas caused by CREBBP mutations
* * *
A study at The University of Texas MD Anderson Cancer Center demonstrated a potential new approach to treating two of the most common subtypes of lymphoma through manipulation of molecular pro . . .